PhD supervision
- Katherine Hill
Selected publications
-
Open access
Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin
Kengo, A., Nabisere, R., Gausi, K., Musaazi, J., Buzibye, A., Omali, D., Aarnoutse, R., Lamorde, M., Dooley, K. E., Sloan, D. J., Denti, P. & Sekaggya-Wiltshire, C., Nov 2023, In: Antimicrobial Agents and Chemotherapy. 67, 11, 14 p., e00430-23.Research output: Contribution to journal › Article › peer-review
-
Open access
Target product profiles: tests for tuberculosis treatment monitoring and optimization
Gupta-Wright, A., den Boon, S., MacLean, E. L., Cirillo, D., Cobelens, F., Gillespie, S. H., Kohli, M., Ruhwald, M., Savic, R., Brigden, G., Gidado, M., Goletti, D., Hanna, D., Hasan, R., Hewison, C., Koura, K. G., Lienhardt, C., Lungu, P., McHugh, T. D. & McKenna, L. & 7 others, , 1 Nov 2023, In: Bulletin of the World Health Organization. 101, 11, p. 730-737 8 p.Research output: Contribution to journal › Article › peer-review
-
Open access
Unexpectedly low drug exposures among Ugandan patients with TB and HIV receiving high-dose rifampicin
Kengo, A., Gausi, K., Nabisere, R., Musaazi, J., Buzibye, A., Omali, D., Aarnoutse, R., Lamorde, M., Dooley, K. E., Sloan, D. J., Sekaggya-Wiltshire, C. & Denti, P., 15 Nov 2023, In: Antimicrobial Agents and Chemotherapy. 67, 11, 6 p., e00431-23.Research output: Contribution to journal › Article › peer-review